{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "NDA018655"
        ],
        "brand_name": [
          "NORPACE CR"
        ],
        "generic_name": [
          "DISOPYRAMIDE PHOSPHATE"
        ],
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "product_ndc": [
          "0025-2732",
          "0025-2752",
          "0025-2762",
          "0025-2742"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DISOPYRAMIDE PHOSPHATE"
        ],
        "rxcui": [
          "209066",
          "209692",
          "309958",
          "309960",
          "636793",
          "636794",
          "902648",
          "902652"
        ],
        "spl_id": [
          "acc7751f-7484-4d53-8a6b-0194f23da1c8"
        ],
        "spl_set_id": [
          "e2aa1642-d262-4520-bc6a-9fd3ad795677"
        ],
        "package_ndc": [
          "0025-2752-31",
          "0025-2762-31",
          "0025-2732-31",
          "0025-2742-31",
          "0025-2742-51"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300252752314",
          "0300252762313",
          "0300252742315",
          "0300252732316"
        ],
        "unii": [
          "N6BOM1935W"
        ]
      },
      "product_type": "Drugs",
      "event_id": "72716",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0520-2016",
      "product_description": "Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.",
      "product_quantity": "a) 4005 bottles, b) 104 bottles",
      "reason_for_recall": "Failed Dissolution Specification",
      "recall_initiation_date": "20151202",
      "center_classification_date": "20151210",
      "termination_date": "20170726",
      "report_date": "20151216",
      "code_info": "Lot #: C150065; C150064, Exp 6/16",
      "more_code_info": ""
    }
  ]
}